BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19864079)

  • 1. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R; Mallick I; Dutta D; Goswami S; Gupta T; Munshi A; Deshpande D; Sarin R
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):974-9. PubMed ID: 19864079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High precision conformal radiotherapy employing conservative margins in childhood benign and low-grade brain tumours.
    Jalali R; Budrukkar A; Sarin R; Sharma DS
    Radiother Oncol; 2005 Jan; 74(1):37-44. PubMed ID: 15683667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Stereotactic Conformal Radiotherapy vs Conventional Radiotherapy on Benign and Low-Grade Brain Tumors: A Randomized Clinical Trial.
    Jalali R; Gupta T; Goda JS; Goswami S; Shah N; Dutta D; Krishna U; Deodhar J; Menon P; Kannan S; Sarin R
    JAMA Oncol; 2017 Oct; 3(10):1368-1376. PubMed ID: 28570730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
    Brown PD; Buckner JC; O'Fallon JR; Iturria NL; Brown CA; O'Neill BP; Scheithauer BW; Dinapoli RP; Arusell RM; Curran WJ; Abrams R; Shaw EG
    J Clin Oncol; 2003 Jul; 21(13):2519-24. PubMed ID: 12829670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.
    Minniti G; Saran F; Traish D; Soomal R; Sardell S; Gonsalves A; Ashley S; Warrington J; Burke K; Mosleh-Shirazi A; Brada M
    Radiother Oncol; 2007 Jan; 82(1):90-5. PubMed ID: 17161483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors.
    Goda JS; Dutta D; Krishna U; Goswami S; Kothavade V; Kannan S; Maitre M; Bano N; Gupta T; Jalali R
    Neuro Oncol; 2020 Nov; 22(11):1677-1685. PubMed ID: 32227185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors.
    Kieffer-Renaux V; Viguier D; Raquin MA; Laurent-Vannier A; Habrand JL; Dellatolas G; Kalifa C; Hartmann O; Grill J
    Pediatr Blood Cancer; 2005 Nov; 45(6):814-9. PubMed ID: 15924360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
    Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
    Marcus KJ; Goumnerova L; Billett AL; Lavally B; Scott RM; Bishop K; Xu R; Young Poussaint T; Kieran M; Kooy H; Pomeroy SL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):374-9. PubMed ID: 15667955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
    Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
    Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma.
    Netson KL; Conklin HM; Wu S; Xiong X; Merchant TE
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1301-6. PubMed ID: 23245284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
    J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy.
    Gupta T; Jalali R; Goswami S; Nair V; Moiyadi A; Epari S; Sarin R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1534-40. PubMed ID: 22342098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results.
    Packer RJ; Sutton LN; Atkins TE; Radcliffe J; Bunin GR; D'Angio G; Siegel KR; Schut L
    J Neurosurg; 1989 May; 70(5):707-13. PubMed ID: 2709111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors.
    Spreafico F; Gandola L; Marchianò A; Simonetti F; Poggi G; Adduci A; Clerici CA; Luksch R; Biassoni V; Meazza C; Catania S; Terenziani M; Musumeci R; Fossati-Bellani F; Massimino M
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1011-9. PubMed ID: 17904307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
    Carrie C; Grill J; Figarella-Branger D; Bernier V; Padovani L; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Baron MH; Clavere P; Chapet S; Maingon P; Alapetite C; Claude L; Laprie A; Dussart S
    J Clin Oncol; 2009 Apr; 27(11):1879-83. PubMed ID: 19273707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
    Greenberger BA; Pulsifer MB; Ebb DH; MacDonald SM; Jones RM; Butler WE; Huang MS; Marcus KJ; Oberg JA; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1060-1068. PubMed ID: 25035209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective assessment of activities of daily living using modified Barthel's Index in children and young adults with low-grade gliomas treated with stereotactic conformal radiotherapy.
    Jalali R; Dutta D; Kamble R; Gupta T; Munshi A; Sarin R; Dinshaw K
    J Neurooncol; 2008 Dec; 90(3):321-8. PubMed ID: 18704269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.